Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan I Silverberg

Showing results (531-540 of 545) with videos related to

Pageof 55
Sort By:
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|April 3, 2022
Bleach baths for atopic dermatitis: A systematic review and meta-analysis including unpublished data, Bayesian interpretation, and GRADELayla Bakaa, Jeffrey M Pernica, Rachel J Couban, et al.
JAMA Dermatology|January 25, 2023
Values and Preferences of Patients and Caregivers Regarding Treatment of Atopic Dermatitis (Eczema): A Systematic ReviewKeon Andre Maleki-Yazdi, Anja Fog Heen, Irene X Zhao, et al.
The British Journal of Dermatology|September 9, 2024
A practical guide to using oral Janus kinase inhibitors for atopic dermatitis from the International Eczema CouncilCarter Haag, Andrew Alexis, Valeria Aoki, et al.
Journal of the American Academy of Dermatology|August 15, 2017
When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema CouncilEric L Simpson, Marjolein Bruin-Weller, Carsten Flohr, et al.
Npj Aging|August 24, 2023
Severe COVID-19 patients exhibit elevated levels of autoantibodies targeting cardiolipin and platelet glycoprotein with age: a systems biology approachDennyson Leandro M Fonseca, Igor Salerno Filgueiras, Alexandre H C Marques, et al.
Journal of Medical Virology|February 1, 2023
Cross-sectional analysis reveals autoantibody signatures associated with COVID-19 severityGabriela C Baiocchi, Aristo Vojdani, Avi Z Rosenberg, et al.
JAMA Dermatology|January 18, 2023
Trends in the Prevalence of Methylchloroisothiazolinone/Methylisothiazolinone Contact Allergy in North America and EuropeMargo J Reeder, Erin Warshaw, Srikanth Aravamuthan, et al.
Nature Communications|March 10, 2022
Autoantibodies targeting GPCRs and RAS-related molecules associate with COVID-19 severityOtavio Cabral-Marques, Gilad Halpert, Lena F Schimke, et al.
Journal of the American Academy of Dermatology|April 29, 2020
The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD): The development and reliability testing of a novel clinical outcome measurement instrument for the severity of atopic dermatitisEric Simpson, Robert Bissonnette, Lawrence F Eichenfield, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|December 18, 2023
Atopic dermatitis (eczema) guidelines: 2023 American Academy of Allergy, Asthma and Immunology/American College of Allergy, Asthma and Immunology Joint Task Force on Practice Parameters GRADE- and Institute of Medicine-based recommendations, Derek K Chu, Lynda Schneider, et al.
Pageof 55

Showing results (531-540 of 545) with videos related to

Sort By:
Pageof 55
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|April 3, 2022
Bleach baths for atopic dermatitis: A systematic review and meta-analysis including unpublished data, Bayesian interpretation, and GRADELayla Bakaa, Jeffrey M Pernica, Rachel J Couban, et al.
JAMA Dermatology|January 25, 2023
Values and Preferences of Patients and Caregivers Regarding Treatment of Atopic Dermatitis (Eczema): A Systematic ReviewKeon Andre Maleki-Yazdi, Anja Fog Heen, Irene X Zhao, et al.
The British Journal of Dermatology|September 9, 2024
A practical guide to using oral Janus kinase inhibitors for atopic dermatitis from the International Eczema CouncilCarter Haag, Andrew Alexis, Valeria Aoki, et al.
Journal of the American Academy of Dermatology|August 15, 2017
When does atopic dermatitis warrant systemic therapy? Recommendations from an expert panel of the International Eczema CouncilEric L Simpson, Marjolein Bruin-Weller, Carsten Flohr, et al.
Npj Aging|August 24, 2023
Severe COVID-19 patients exhibit elevated levels of autoantibodies targeting cardiolipin and platelet glycoprotein with age: a systems biology approachDennyson Leandro M Fonseca, Igor Salerno Filgueiras, Alexandre H C Marques, et al.
Journal of Medical Virology|February 1, 2023
Cross-sectional analysis reveals autoantibody signatures associated with COVID-19 severityGabriela C Baiocchi, Aristo Vojdani, Avi Z Rosenberg, et al.
JAMA Dermatology|January 18, 2023
Trends in the Prevalence of Methylchloroisothiazolinone/Methylisothiazolinone Contact Allergy in North America and EuropeMargo J Reeder, Erin Warshaw, Srikanth Aravamuthan, et al.
Nature Communications|March 10, 2022
Autoantibodies targeting GPCRs and RAS-related molecules associate with COVID-19 severityOtavio Cabral-Marques, Gilad Halpert, Lena F Schimke, et al.
Journal of the American Academy of Dermatology|April 29, 2020
The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD): The development and reliability testing of a novel clinical outcome measurement instrument for the severity of atopic dermatitisEric Simpson, Robert Bissonnette, Lawrence F Eichenfield, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|December 18, 2023
Atopic dermatitis (eczema) guidelines: 2023 American Academy of Allergy, Asthma and Immunology/American College of Allergy, Asthma and Immunology Joint Task Force on Practice Parameters GRADE- and Institute of Medicine-based recommendations, Derek K Chu, Lynda Schneider, et al.
Pageof 55